AE Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Buy
+11,057
New +$107K ﹤0.01% 1777
2024
Q1
– Sell
-24,918
Closed -$389K – 1691
2023
Q4
$389K Sell
24,918
-11,913
-32% -$195K ﹤0.01% 1581
2023
Q3
$453K Buy
36,831
+4,646
+14% +$69.1K ﹤0.01% 1429
2023
Q2
$517K Buy
+32,185
New +$530K ﹤0.01% 1377

Other funds holding NEO

AE Wealth Management's NEO Position: Q2 2026 in Review

AE Wealth Management opened a new position in NeoGenomics (NEO) in Q2 2026: 11,057 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #1777 among its holdings. This is a return to the name: AE Wealth Management previously reported a position in NEO as recently as Q4 2023.

AE Wealth Management first reported a position in NEO in Q2 2023 and has held it in 4 quarters since. The position peaked at $517K in Q2 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • AE Wealth Management held 11,057 shares of NeoGenomics worth $161K as of Q2 2026.
  • NeoGenomics was a new AE Wealth Management position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #1777 holding.
  • AE Wealth Management first reported a position in NeoGenomics in Q2 2023 and has held it in 4 quarters since.
  • AE Wealth Management's NeoGenomics position peaked at $517K in Q2 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.